Prenetics Global Limited (PRE) Stock Analysis
Inst Constrain edge
Consumer Defensive · Packaged Foods
Hold if already holding. Not a fresh buy at $23.35, but acceptable to hold if already in. Reason: Market cap $369M below $400M minimum.
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in... Read more
Hold if already holding. Not a fresh buy at $23.35, but acceptable to hold if already in. Reason: Market cap $369M below $400M minimum. Chart setup: No clear chart pattern; technical signals are mixed. Market cap $369M below $400M minimum. Not in investable universe. Score 5.6/10, moderate confidence.
Passes 7/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 53d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum. Suitability: aggressive.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
3 floor-breakers·1 ceiling hit
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Unprofitable operations — net margin -30.4%. Quality floor flags this regardless of sector context.static
No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $23.35, but acceptable to hold if already in. Reason: Market cap $369M below $400M minimum. Chart setup: No clear chart pattern; technical signals are mixed. Market cap $369M below $400M minimum. Not in investable universe. Target $30.60 (+31.0%), stop $21.66 (−7.8%), A.R:R 2.1:1. Score 5.6/10, moderate confidence.
Take-profit target: $30.60 (+31.4% upside). Target $30.60 (+31.0%), stop $21.66 (−7.8%), A.R:R 2.1:1. Stop-loss: $21.66.
Market cap $369M below $400M minimum.
Prenetics Global Limited trades at a P/E of N/A (forward -8.2). TrendMatrix value score: 8.9/10. Verdict: Hold.
8 analysts cover PRE with a consensus score of 4.0/5. Average price target: $35.
What does Prenetics Global Limited do?Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company...
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.